XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Garbage stock , garbage events

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Nov 25, 2021 10:51am

128 Views

Post# 34165084

RE:RE:RE:RE:RE:Garbage stock , garbage events

AK, you go and Preach and Teach your Boiler Room mates that you need cheap shares like the rest of the Fund Managers [AB42] from the BOGUS RoadRunner Financiers in Calgary, NY and Boston.
You operate out of a STRIP MALL, derailed Dr. Xortx in IPO NASDAQ my friends, walked away with 30% DISCOUNT.
Get a REAL CEO with Wall St experience and then see how much he raises in NASDAQ IPO, it will BLOW the SHARKS OUT of the WATER !!